Literature DB >> 36180691

Functional Investigation of Melatonin Receptor Activation by Homogenous cAMP Assay.

Erika Cecon1, Jean-Luc Guillaume1, Ralf Jockers2.   

Abstract

Cyclic adenosine monophosphate (cAMP) is an important ubiquitous second messenger and one of the major pathways transducing the activation of G protein-coupled receptors (GPCRs). Quantifying intracellular levels of cAMP in an accurate and high-throughput manner is, therefore, of high interest to access functional responses of GPCRs. The neurohormone melatonin is selectively recognized by two GPCRs in mammals, named MT1 and MT2. Both have an inhibitory action on intracellular cAMP levels. Here, we describe a homogeneous high-throughput-compatible methodology routinely used in our laboratory to measure cAMP levels following activation of melatonin receptors.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Adenylyl cyclase; Melatonin receptors; TR-FRET; cAMP

Mesh:

Substances:

Year:  2022        PMID: 36180691     DOI: 10.1007/978-1-0716-2593-4_22

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  17 in total

Review 1.  Melatonin receptors: molecular pharmacology and signalling in the context of system bias.

Authors:  Erika Cecon; Atsuro Oishi; Ralf Jockers
Journal:  Br J Pharmacol       Date:  2017-08-17       Impact factor: 8.739

2.  Inhibitory and stimulatory G proteins of adenylate cyclase: cDNA and amino acid sequences of the alpha chains.

Authors:  K A Sullivan; Y C Liao; A Alborzi; B Beiderman; F H Chang; S B Masters; A D Levinson; H R Bourne
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

3.  Journal of Pineal Research guideline for authors: Defining and characterizing melatonin targets.

Authors:  Erika Cecon; Céline Legros; Jean A Boutin; Ralf Jockers
Journal:  J Pineal Res       Date:  2020-12-17       Impact factor: 13.007

Review 4.  Update on melatonin receptors: IUPHAR Review 20.

Authors:  Ralf Jockers; Philippe Delagrange; Margarita L Dubocovich; Regina P Markus; Nicolas Renault; Gianluca Tosini; Erika Cecon; Darius P Zlotos
Journal:  Br J Pharmacol       Date:  2016-08-08       Impact factor: 8.739

5.  Amyloid β peptide directly impairs pineal gland melatonin synthesis and melatonin receptor signaling through the ERK pathway.

Authors:  Erika Cecon; Min Chen; Marina Marçola; Pedro A C Fernandes; Ralf Jockers; Regina P Markus
Journal:  FASEB J       Date:  2015-03-10       Impact factor: 5.191

6.  Melatonin MT1 and MT2 receptor ERK signaling is differentially dependent on Gi/o and Gq/11 proteins.

Authors:  Min Chen; Erika Cecon; Angeliki Karamitri; Wenwen Gao; Romain Gerbier; Raise Ahmad; Ralf Jockers
Journal:  J Pineal Res       Date:  2020-03-06       Impact factor: 13.007

Review 7.  The Molecular Basis of G Protein-Coupled Receptor Activation.

Authors:  William I Weis; Brian K Kobilka
Journal:  Annu Rev Biochem       Date:  2018-06-20       Impact factor: 23.643

8.  Design and validation of the first cell-impermeant melatonin receptor agonist.

Authors:  Florence Gbahou; Erika Cecon; Guillaume Viault; Romain Gerbier; Frederic Jean-Alphonse; Angeliki Karamitri; Gérald Guillaumet; Philippe Delagrange; Robert M Friedlander; Jean-Pierre Vilardaga; Franck Suzenet; Ralf Jockers
Journal:  Br J Pharmacol       Date:  2017-06-11       Impact factor: 8.739

9.  Detection of recombinant and endogenous mouse melatonin receptors by monoclonal antibodies targeting the C-terminal domain.

Authors:  Erika Cecon; Anna Ivanova; Marine Luka; Florence Gbahou; Anne Friederich; Jean-Luc Guillaume; Patrick Keller; Klaus Knoch; Raise Ahmad; Philippe Delagrange; Michele Solimena; Ralf Jockers
Journal:  J Pineal Res       Date:  2019-01-17       Impact factor: 13.007

10.  Immortalized cells from the rat suprachiasmatic nucleus express functional melatonin receptors.

Authors:  Moisés A Rivera-Bermúdez; Monica I Masana; Gregory M Brown; David J Earnest; Margarita L Dubocovich
Journal:  Brain Res       Date:  2004-03-26       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.